A new study finds that vitamin B3 (nicotinamide) at 500 mg twice daily reduces basal cell carcinoma and squamous cell carcinoma risk in veterans over a 25-year period.

Colino is a contributor for TIME. Colino is a contributor for TIME. Skin cancer is the most common type of cancer in the U.S., and it has increased dramatically in the last 50 years. Melanoma, the ...

Researchers at the UT Austin Portugal Program have developed what they say is a remarkable cancer treatment that combines LED ...

Older adults are at a high risk of skin cancer due to a lifetime of sun exposure and physical changes related to age. Skin cancer is the most common form of cancer worldwide and disproportionately ...

A new wearable patch can detect early signs of the deadliest form of skin cancer. The wireless device allows screening of ...

Basal cell carcinoma accounts for about 80% of skin cancer diagnoses, the American Cancer Society estimates, and often develops on face, head, neck and arms — areas on the body that receive a lot of ...

Researchers at Fox Chase Cancer Center, Temple University's College of Engineering, and the Lewis Katz School of Medicine at ...

Scientists have discovered why gray hair and deadly melanoma are connected through the same stem cells that respond to DNA ...

Skin cancer can occur anywhere, but scars and burn injuries are at a higher risk. Wearing sunscreen and, when possible, avoiding UV radiation can lower the risk of developing skin cancer in a scar.

A massive Veterans Affairs study has confirmed that nicotinamide may offer real protection against skin cancer. Patients who ...

"It's not a replacement for sunscreen, it works differently. I recommend that if you're using sunscreen or if you are ...

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for ...